XML 144 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Property and Equipment

           
   (in thousands) 
   September 30, 2024   December 31, 2023 
Furniture, fixtures, and equipment   1,466    1,448 
Less: accumulated depreciation   (1,349)   (1,321)
Property and equipment, net  $117   $127 

   2023   2022 
   (in thousands)
December 31,
 
   2023   2022 
Furniture, fixture and equipment  $1,448   $2,233 
Less: accumulated depreciation   (1,321)   (2,038)
Property and equipment, net  $127   $195 
Schedule of Available of Sale  

Mutual Funds classified as available for sale consisted of:

 

(in thousands)

December 31, 2023

 

Securities 

Fair

Value

   Short-Term Investments 
Mutual Funds  $7,631   $7,631 
Totals  $7,631   $7,631 
Mutual Funds classified as available for sale consisted of:

 

(in thousands)

December 31, 2022

 

Securities  Fair Value   Short-Term Investments 
Mutual Funds  $7,137   $7,137 
Totals  $7,137   $7,137 
 
Schedule of Equity Securities  

     
Securities    
Net gain recognized during the year on equity securities  $200 
Less: Net gains and losses recognized during the year on equity securities sold during the year   (176)
Unrealized gains and losses recognized during the year on equity securities still held at the end of the year  $376 
(in thousands)

December 31, 2022

 

     
Securities    
Net losses recognized during the period on equity securities  $(1,679)
Less: Net gains and losses recognized during the period on equity securities sold during the year   (751)
Unrealized gains and losses recognized during the reporting period on equity securities still held at the end of the year  $(928)

 
Schedule of Options and Equity Estimated Based on Weighted Average Assumptions  

   Year Ended December 31, 
   2023   2022 
Risk-free interest rate   4.37%   1.74% - 3.88% 
Expected dividend yield        
Expected life   10 years    10 years 
Expected volatility   99.91%   98.43% - 107.18% 
Weighted average grant date fair value for options issued   $0.43 per option for 400,000 options    $0.51 per option for 850,000 options 
Schedule of Warrants Outstanding and Exercisable  

Information regarding warrants outstanding and exercisable into shares of common stock is summarized below:

 

   2023   2022 
      Warrant   Weighted
Average
Exercise
      Warrant   Weighted
Average
Exercise
 
   Shares   Price   Price   Shares   Price   Price 
Outstanding, beginning of year
 
   226,610    $ 0.99-132.00   $9.10    294,939    $0.99 469.92   $15.19 
Granted                        
Expired   (74,450)   17.05    17.05    (68,215)   469.92    469.92 
Exercised               (114)   8.80    8.80 
Outstanding, end of year   152,160    $ 0.99-8.80   $8.03    226,610    $ 0.99-132.00   $9.10 
Exercisable   152,160    $ 0.99-8.80   $8.03    226,610    $ 0.99-132.00   $9.10 
Weighted average remaining contractual life   .75 years              .94 years           
Years exercisable   2024              2023-2024           
Share-Based Payment Arrangement, Employee [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Vest Stock Option Activity

Stock option activity for employees:

Schedule of Stock Option Activity

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding June 30, 2024   2,407,775   $2.50    8.70   $ 
Granted                
Forfeited                
Expired   (95)            
Outstanding September 30, 2024   2,407,680   $2.44    8.70   $ 
Vested and expected to vest September 30, 2024   2,407,680   $2.44    8.70   $ 
Exercisable September 30, 2024   2,341,014   $1.66    7.17   $ 

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2024   2,408,438   $2.50    8.70   $ 
Granted                
Forfeited                
Expired   (758)            
Outstanding September 30, 2024   2,407,680   $2.44    8.70   $ 
Vested and expected to vest September 30, 2024   2,407,680   $2.44    8.70   $ 
Exercisable September 30, 2024   2,341,014   $1.66    7.17   $ 
 

Vested stock option activity for employees:

 

   Number of   Weighted Average Exercise   Weighted
Average
Remaining
Contracted
Term
   Aggregate Intrinsic 
   Options   Price   (Years)   Value 
Outstanding December 31, 2021   1,498,798   $4.22    9.11     
Granted   550,000    0.49    9.71     
Forfeited   (28,584)   17.71         
Expired                
Outstanding December 31, 2022   2,020,214   $3.01    8.86     
Granted   400,000    0.47    10.17     
Forfeited   (7,601)   9.68          
Expired   (4,175)   41.61         
Outstanding December 31, 2023   2,408,438   $2.50    8.70     
Vested and expected to vest at December 31, 2023   2,041,772   $1.90    6.73     
Exercisable at December 31, 2023   2,041,772   $1.90    6.73     
Schedule of Unvested Stock Option Activity

Unvested stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested June 30, 2024   166,666   $4.11    18.87   $ 
Granted                
Expired   (95)            
Vested   (99,905)   0.47    7.17     
Unvested September 30, 2024   66,666   $9.61    36.22   $ 

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2024   366,666   $2.13    12.44   $ 
Granted                
Expired   (758)            
Vested   (299,242)   0.47    7.17     
Unvested September 30, 2024   66,666   $9.61    36.22   $ 

 

Unvested stock option activity for employees:

 

   Number of   Weighted Average Exercise   Average Remaining Contracted Term   Aggregate Intrinsic 
   Options   Price   (Years)   Value 
Unvested December 31, 2021   412,500   $4.15    5.85     
Granted   550,000    0.49    9.71     
Vested   (541,590)   1.31    9.73     
Forfeited   (28,584)   17.71         
Unvested December 31, 2022   392,326   $0.80    8.86     
Granted   400,000    0.47    10.17     
Vested   (413,884)   1.90    6.73     
Forfeited   (7,601)   9.68         
Expired   (4,175)   41.61         
Unvested December 31, 2023   366,666   $2.13    12.44     
Share-Based Payment Arrangement, Nonemployee [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Vest Stock Option Activity

Stock option activity for non-employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding June 30, 2024   885,055   $2.02    9.23   $ 
Granted                
Forfeited                
Expired   (95)            
Outstanding September 30, 2024   884,960   $1.88    9.23   $ 
Vested and expected to vest September 30, 2024   884,960   $1.88    9.23   $ 
Exercisable September 30, 2024   729,960   $1.87    10.06   $ 

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2024   885,055   $2.02    9.23   $ 
Granted                
Forfeited                
Expired   (95)            
Outstanding September 30, 2024   884,960   $1.88    9.23   $ 
Vested and expected to vest September 30, 2024   884,960   $1.88    9.23   $ 
Exercisable September 30, 2024   729,960   $1.87    10.06   $ 
 

Vested stock option activity for non-employees:

 

   Number of   Weighted Average Exercise   Weighted Average Remaining Contracted Term   Aggregate Intrinsic 
   Options   Price   (Years)   Value 
Outstanding December 31, 2021   279,723   $6.12    7.93     
Granted   300,000    0.54    9.68     
Exercised                
Forfeited   (568)   153.12         
Outstanding December 31, 2022   579,155   $3.09    8.36     
Granted   360,000    0.46    10.04     
Exercised                
 Expired   (653)   145.24         
Forfeited   (53,447)   1.31         
Outstanding December 31, 2023   885,055   $2.02    9.23     
Vested and expected to vest at December 31, 2023   550,055   $2.56    10.02     
Exercisable at December 31, 2023   550,055   $2.56    10.02     
Schedule of Unvested Stock Option Activity

Unvested stock option activity for non-employees:

 

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested June 30, 2024   155,001   $3.42    11.30   $ 
Granted                
Expired   (95)            
Vested   95    0.46    10.18     
Unvested September 30, 2024   155,001   $3.42    11.31   $ 
 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2024   335,001   $1.83    10.70   $ 
Granted                
Expired   (95)            
Vested   (179,905)   0.46    10.18     
Unvested September 30, 2024   155,001   $3.42    11.31   $ 

 

Unvested stock option activity for non-employees:

 

   Number of   Weighted Average Exercise   Weighted
Average
Remaining
Contracted
Term
   Aggregate Intrinsic 
   Options   Price   (Years)   Value 
Unvested December 31, 2021   97,831   $3.89    7.82     
Granted   300,000    0.54    9.68     
Vested   (229,053)   0.82         
Forfeited   (1,989)            
Unvested December 31, 2022   166,789   $4.05    9.49     
Granted   360,000    0.46    10.18     
Vested   (137,565)   0.47    9.47     
Expired   (776)   145.24         
Forfeited   (53,447)   1.31         
Unvested December 31, 2023   335,001   $1.83    10.70     
Equity Incentive Plan 2009 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Vest Stock Option Activity  

Information regarding the options approved by the Board of Directors under the Equity Plan of 2009 is summarized below. The plan expired on June 24, 2019:

 

   2023   2022 
       Option   Weighted
Average
Exercise
       Option   Weighted
Average
Exercise
 
   Shares   Price   Price   Shares   Price   Price 
Outstanding, beginning of year   124,399    13.20 1,003.20    22.23    128,504    13.20 2,127.84    25.58 
Granted                        
Forfeited   (5,047)   9.68-327.36    57.79    (4,105)   16.76-2,127.84    129.88 
Exercised                        
Outstanding, end of year   119,352    13.20-2,127.84    20.72    124,399    13.20-1,003.20    22.23 
Exercisable, end of year   119,352    13.20-2,127.84         124,399    13.20-1,003.20      
Weighted average remaining contractual life (years)   4.06 years              5.98 years           
2018 Equity Incentive Plans [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Vest Stock Option Activity  

Information regarding the options approved by the Board of Directors under the Equity Plan of 2018 is summarized below:

 

   2023   2022 
       Option   Weighted
Average
Exercise
       Option   Weighted
Average
Exercise
 
   Shares   Price   Price   Shares   Price   Price 
Outstanding, beginning of year   2,474,971    0.31-9.68    1.72    1,650,017    1.11 9.68    2.35 
Granted   400,000    0.47-0.47    0.47    850,000    0.31 1.71    0.51 
Forfeited   (60,829)   0.31-9.68    1.98    (25,046)   1.85 9.68    1.86 
Exercised                        
Outstanding, end of year   2,814,142    0.31-9.68    1.54    2,474,971    0.31 9.68    1.72 
Exercisable, end of year   2,397,474    0.31-327.36    4.71    1,916,637    0.41 9.68    2.22 
Weighted average remaining contractual life (years)   7.96 years              9.65 years           
Available for future grants   1,210,286              466,120